Dachaigh › Ailsean fala › Tennessee › Nashville
Sgrùdaidhean clionaigeach Ailsean fala ann an Nashville, TN
Tha 13 sgrùdaidhean airson Ailsean fala a’ lorg phàirtichean aig làraichean ann agus timcheall air Nashville (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A’ fastadhÌre 3
- Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060), Nashville
- Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0015), Nashville
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
A’ fastadhÌre 1
- Sarah Cannon Cancer Institute, Nashville
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
A’ fastadhÌre 3
- Quetzal Site 12, Nashville
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
A’ fastadhÌre 1
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A’ fastadhÌre 3
- Tennessee Oncology, Nashville
- TriStar Centennial Medical Center, Nashville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A’ fastadhÌre 1
- Vanderbilt University Medical Center, Nashville
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
A’ fastadhÌre 1
- Sarah Cannon Research Institute - Oncology Partners, Nashville
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
A’ fastadhÌre 2
- Vanderbilt University, Ingram Cancer Center, Nashville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A’ fastadhSgrùdadh amharc
- Vanderbilt University, Nashville
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
A’ fastadhÌre 3
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
A’ fastadhÌre 1
- TriStar Bone Marrow Transplant, Nashville
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
A’ fastadhÌre 1/2
- SCRI Oncology Partners, Nashville
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
A’ fastadhÌre 1
- TriStar Bone Marrow Transplant, Nashville
Sgrùdaidhean Ailsean fala ann am bailtean eile
- Houston, TX46 sgrùdaidhean
- New York City, NY26 sgrùdaidhean
- Boston, MA25 sgrùdaidhean
- Washington, DC19 sgrùdaidhean
- Seattle, WA18 sgrùdaidhean
- Baltimore, MD18 sgrùdaidhean
- Los Angeles, CA17 sgrùdaidhean
- Durham, NC16 sgrùdaidhean
- Chicago, IL15 sgrùdaidhean
- Philadelphia, PA14 sgrùdaidhean
- Columbus, OH13 sgrùdaidhean
- Edison, NJ13 sgrùdaidhean
Sgrùdaidhean eile ann an Nashville
- Aillse Sgamhain Neo-chealla-beag97 sgrùdaidhean
- Aillse a' bhroilleach81 sgrùdaidhean
- Ailse metastatach70 sgrùdaidhean
- Aillse colorectal69 sgrùdaidhean
- Aillse (gach seòrsa)65 sgrùdaidhean
- Cancer Ovarian49 sgrùdaidhean
- Aillse Prostata43 sgrùdaidhean
- Ailseachadh nan Sgamhan40 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil39 sgrùdaidhean
- Cancer Pancreatic39 sgrùdaidhean
- Ailse Endometrial38 sgrùdaidhean
- Melanoma33 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.